Hormonal diseases

146 trials 57 recruiting

Filter these 146 trials by phase, country and sponsor.

Open in Search →

Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Not authorised

2022-503126-12-00 Hypoparathyroidism 5
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr… Not authorised

2025-523820-26-00 Growth Hormone Deficiency (GHD) 5
Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial Not authorised

2022-500669-28-00 Osteoporosis 4
(WHAT!) – RCT: Open-label randomized controlled trial for the effects of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/… Pending

2024-517127-40-00 Migraine 11
Tolerability and acceptance of two oral hydrocortisone medications for Pediatrics. Pending

2024-519149-31-00 Adrenal hyperplasia or isolated primary adrenal insuffi 6
Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial Pending

2023-509259-15-01 Polycystic ovary syndrome 6
A Study Evaluating Mibavademab Treatment of Obesity due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults Pending

2024-518674-14-00 Monogenic obesity 5
PLatelet aggregation and Aspirin low response in Type One Diabetes and the association with vascular damage and diabetic Nephropathy Pending

2024-520324-29-00 Atherosclerotic cardiovascular disease 4
Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD) Pending

2023-510312-40-00 Secondary hyperparathyroidism 6
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO) Pending

2023-504654-35-00 Graves Ofthalmopathy 4
MAGNEFFICIENT: A prospective, randomized, double-blind, placebo-controlled, single-center clinical trial. Pending

2025-522839-33-00 Postoperative Hypoparathyroidism after thyroid surgery. 5
Oxytocine and migraine Pending

2023-504690-21-00 This is a study in healthy volunteers. We will study t 3
Surgical versus Medical Treatment in Microprolactinomas (SUMET PRO) Pending

2024-516383-28-01 Microprolactinomas 5
Ultrasound-guided Radiofrequency Ablation versus radioactive Iodine as treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid N… Pending

2024-515602-34-01 Hyperactive thyroid nodules 11
Etude de bioéquivalence entre Circadin et Melatonin PILEJE LP 2 mg Pending

2024-519932-17-00 Primary insomnia characterized by poor quality of sleep 2
The OMNIMARA Trial Pending

2024-519935-41-00 Short predicted height 5
Impact of treatment with TransCon PTH on Quality of Life, cognitive function, brain structure, and cerebral capillary bloodflow in patients … Pending

2025-523930-14-00 Hypoparathyroidism 6
The FIND study Pending

2024-518908-46-00 ACTH-dependent hypercortisolism 5
Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared… Pending

2025-521830-27-00 Post-bariatric hypoglycaemia 3
A phase III, randomized, controlled, open label, no profit, single-center intervention study to compare the effect of a conservative (antith… Pending

2024-518452-23-00 Graves' disease and Graves' orbitophaty 5
The GranStone Trial Pending

2026-525608-85-00 Paraffin Oil Induced Granulomatous Disease 10
CUSHMAH - Benefit of steroidogenesis inhibitors in Mild Cushing syndrome (Mild Autonomous Cortisol Secretion): a randomized trial in patient… Pending

2023-507010-27-00 Primary Bilateral Macronodular Adrenal Hyperplasia caus 5
Impact of Intraoperative Arteriography with Indocyanine Green in Preserving the Parathyroid Glands During Total Thyroidectomy With or Withou… Pending

2023-509130-18-00 Hypothyroidism 5
COMPASS - COpenhagen MenoPAuSe Study Pending

2025-522558-37-00 Menopause 4